RESUMO
The conspicuous bright golden to orange-reddish coloration of species of the basidiomycete genus Laetiporus is a hallmark feature of their fruiting bodies, known among mushroom hunters as the "chicken of the woods". This report describes the identification of an eight-domain mono-modular highly reducing polyketide synthase as sole enzyme necessary for laetiporic acid biosynthesis. Heterologous pathway reconstitution in both Aspergillus nidulans and Aspergillus niger verified that LpaA functions as a multi-chain length polyene synthase, which produces a cocktail of laetiporic acids with a methyl-branched C26-C32 main chain. Laetiporic acids show a marked antifungal activity on Aspergillus protoplasts. Given the multiple products of a single biosynthesis enzyme, our work underscores the diversity-oriented character of basidiomycete natural product biosynthesis.
Assuntos
Antifúngicos/metabolismo , Polienos/metabolismo , Policetídeo Sintases/metabolismo , Polyporales/enzimologia , Antifúngicos/isolamento & purificação , Antifúngicos/farmacologia , Aspergillus nidulans/efeitos dos fármacos , Aspergillus niger/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Polienos/isolamento & purificação , Polienos/farmacologia , Policetídeo Sintases/genética , Polyporales/química , Polyporales/genética , Polyporales/metabolismoRESUMO
Bendamustine, an anticancer drug with alkylating properties, is widely used to treat hematological malignancies. Since the nitrogen mustard family alkylators induce DNA damages and have been associated with an elevated risk of second malignancy, current study evaluates the cytotoxic, mutagenic, and recombinogenic effects of bendamustine by using, respectively the mitotic index assay, the in vitro mammalian cell micronucleus test (Mnvit) and the chromosome aberration (CA) test in human peripheral lymphocytes, and the in vivo homozygotization assay in Aspergillus nidulans, which detects the loss of heterozygosity (LOH) due to somatic recombination. Bendamustine (6.0 µg/ml, 9.0 µg/ml, and 12.0 µg/ml) induced a statistically significant concentration-related increase in the frequencies of micronuclei and a significant reduction in the cytokinesis block proliferation index (CBPI) rates when compared to negative control. In the CA test, bendamustine significantly increased the frequencies of structural aberrations at the three tested concentrations when compared to the negative control. Aspergillus nidulans diploids, obtained after bendamustine treatment (6.0 µg/ml, 12.0 µg/ml, and 24.0 µg/ml), produced, after haploidization, homozygotization index (HI) rates higher than 2.0 and significantly different from the negative control. Since bendamustine showed genotoxic effects in all tested concentrations, two of them corresponding to the peak plasma concentrations observed in cancer patients treated with bendamustine, data provided in the current research work may be useful to identify the most appropriate dosage regimen to achieve the efficacy and safety of this anticancer medication.
Assuntos
Antineoplásicos Alquilantes/toxicidade , Aspergillus nidulans/efeitos dos fármacos , Cloridrato de Bendamustina/toxicidade , Aberrações Cromossômicas/induzido quimicamente , Perda de Heterozigosidade/efeitos dos fármacos , Linfócitos/efeitos dos fármacos , Adolescente , Adulto , Aspergillus nidulans/genética , Células Cultivadas , Relação Dose-Resposta a Droga , Humanos , Linfócitos/patologia , Micronúcleos com Defeito Cromossômico/induzido quimicamente , Testes para Micronúcleos , Adulto JovemRESUMO
Plocabulin (PM060184) is a microtubule depolymerizing agent with potent antiproliferative activity undergoing phase II clinical trials for the treatment of solid tumors. Plocabulin shows antifungal activity virtually abolishing growth of the filamentous fungus Aspergillus nidulans. A. nidulans hyphae depend both on mitotic and interphase microtubules, as human cells. Here, we exploited the A. nidulans genetic amenability to gain insight into the mechanism of action of plocabulin. By combining mutations in the two A. nidulans ß-tubulin isotypes we obtained a plocabulin-insensitive strain, showing that ß-tubulin is the only molecular target of plocabulin in fungal cells. From a genetic screen, we recovered five mutants that show plocabulin resistance but do not carry mutations in ß-tubulin. Resistance mutations resulted in amino acid substitutions in (1) two subunits of the eukaryotic translation initiation factor eIF2B activating the General Amino Acid Control, (2) TIM44, an essential component of the inner mitochondrial membrane translocase, (3) two transcription factors of the binuclear zinc cluster family potentially interfering with the uptake or efflux of plocabulin. Given the conservation of some of the identified proteins and their respective cellular functions in the tumor environment, our results pinpoint candidates to be tested as potential biomarkers for determination of drug efficiency.
Assuntos
Antineoplásicos/farmacologia , Aspergillus nidulans/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos , Microtúbulos/efeitos dos fármacos , Policetídeos/farmacologia , Pironas/farmacologia , Farmacorresistência Fúngica , Proteínas Fúngicas/genética , Mutação de Sentido Incorreto , Tubulina (Proteína)/genéticaRESUMO
Most eukaryotic peroxiredoxins (Prxs) are readily inactivated by a high concentration of hydrogen peroxide (H2O2) during catalysis owing to their "GGLG" and "YF" motifs. However, such oxidative stress sensitive motifs were not found in the previously identified filamentous fungal Prxs. Additionally, the information on filamentous fungal Prxs is limited and fragmentary. Herein, we cloned and gained insight into Aspergillus nidulans Prx (An.PrxA) in the aspects of protein properties, catalysis characteristics, and especially H2O2 tolerability. Our results indicated that An.PrxA belongs to the newly defined family of typical 2-Cys Prxs with a marked characteristic that the "resolving" cysteine (CR) is invertedly located preceding the "peroxidatic" cysteine (CP) in amino acid sequences. The inverted arrangement of CR and CP can only be found among some yeast, bacterial, and filamentous fungal deduced Prxs. The most surprising characteristic of An.PrxA is its extraordinary ability to resist inactivation by extremely high concentrations of H2O2, even that approaching 600 mM. By screening the H2O2-inactivation effects on the components of Prx systems, including Trx, Trx reductase (TrxR), and Prx, we ultimately determined that it is the robust filamentous fungal TrxR rather than Trx and Prx that is responsible for the extreme H2O2 tolerence of the An.PrxA system. This is the first investigation on the effect of the electron donor partner in the H2O2 tolerability of the Prx system.
Assuntos
Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/enzimologia , Peróxido de Hidrogênio/metabolismo , Oxidantes/metabolismo , Estresse Oxidativo , Peroxirredoxinas/metabolismo , Sequência de Aminoácidos , Aspergillus nidulans/genética , Aspergillus nidulans/fisiologia , Clonagem Molecular , Deleção de Genes , Peroxirredoxinas/genética , Alinhamento de Sequência , Homologia de Sequência de AminoácidosRESUMO
Aurovertins are the structurally diverse polyketides that distribute widely in different fungal species. They feature a 2,6-dioxabicyclo[3.2.1]-octane ring in structure and exhibit the potential antitumor activity against breast cancer as F1-ATPase ß subunit inhibitor. In this study, we constructed the biosynthetic pathway of aurovertin in an Aspergillus nidulans host and obtained seven aurovertin-type compounds. Surprisingly, three new aurovertin geometric isomers were characterized. By introducing an inducible promoter xylP(p) in the pathway gene acyltransferase aurG, we can control the product ratios among different aurovertin compounds by adding glucose and/or inducer xylose. The yields of aurovertins could be increased up to about 20 times by adding a constitutive promoter gpdA(p) to transcription factor AurF, which indicates AurF's positive role in the biosynthesis of aurovertin. Taken together, our results provided not only an efficient way to generate bioactive fungal natural products but also realized the rational controlling their yields with designed promoters.
Assuntos
Aspergillus nidulans/metabolismo , Aurovertinas/metabolismo , Vias Biossintéticas/genética , Aciltransferases/genética , Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/enzimologia , Aspergillus nidulans/genética , Aurovertinas/análise , Aurovertinas/química , Aurovertinas/isolamento & purificação , Sítios de Ligação , Produtos Biológicos/metabolismo , Vias Biossintéticas/fisiologia , Glucose/farmacologia , Cinética , Regiões Promotoras Genéticas , Xilose/farmacologiaRESUMO
Estrogenic active compounds are present in a variety of sources and may alter biological functions in vertebrates. Therefore, it is crucial to develop innovative analytical systems that allow us to screen a broad spectrum of matrices and deliver fast and reliable results. We present the adaptation and validation of a fungal biosensor for the detection of estrogen activity in cow derived samples and tested the clinical applicability for pregnancy diagnosis in 140 mares and 120 cows. As biosensor we used a previously engineered genetically modified strain of the filamentous fungus Aspergillus nidulans, which contains the human estrogen receptor alpha and a reporter construct, in which ß-galactosidase gene expression is controlled by an estrogen-responsive-element. The estrogen response of the fungal biosensor was validated with blood, urine, feces, milk and saliva. All matrices were screened for estrogenic activity prior to and after chemical extraction and the results were compared to an enzyme immunoassay (EIA). The biosensor showed consistent results in milk, urine and feces, which were comparable to those of the EIA. In contrast to the EIA, no sample pre-treatment by chemical extraction was needed. For 17ß-estradiol, the biosensor showed a limit of detection of 1ng/L. The validation of the biosensor for pregnancy diagnosis revealed a specificity of 100% and a sensitivity of more than 97%. In conclusion, we developed and validated a highly robust fungal biosensor for detection of estrogen activity, which is highly sensitive and economic as it allows analyzing in high-throughput formats without the necessity for organic solvents.
Assuntos
Aspergillus nidulans/efeitos dos fármacos , Técnicas Biossensoriais/métodos , Estrogênios/análise , Estrogênios/farmacologia , Animais , Bovinos , Feminino , Cavalos , Limite de Detecção , Gravidez , Reprodutibilidade dos TestesRESUMO
One of the drawbacks during second-generation biofuel production from plant lignocellulosic biomass is the accumulation of glucose, the preferred carbon source of microorganisms, which causes the repression of hydrolytic enzyme secretion by industrially relevant filamentous fungi. Glucose sensing, subsequent transport and cellular signalling pathways have been barely elucidated in these organisms. This study therefore characterized the transcriptional response of the filamentous fungus Aspergillus nidulans to the presence of high and low glucose concentrations under continuous chemostat cultivation with the aim to identify novel factors involved in glucose sensing and signalling. Several transcription factor- and transporter-encoding genes were identified as being differentially regulated, including the previously characterized glucose and xylose transporter HxtB. HxtB was confirmed to be a low affinity glucose transporter, localizing to the plasma membrane under low- and high-glucose conditions. Furthermore, HxtB was shown to be involved in conidiation-related processes and may play a role in downstream glucose signalling. A gene predicted to encode the protein kinase PskA was also identified as being important for glucose metabolism. This study identified several proteins with predicted roles in glucose metabolic processes and provides a foundation for further investigation into the response of biotechnologically important filamentous fungi to glucose.
Assuntos
Aspergillus nidulans/metabolismo , Metabolismo dos Carboidratos , Proteínas Facilitadoras de Transporte de Glucose/metabolismo , Glucose/metabolismo , Transdução de Sinais , Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/genética , Metabolismo dos Carboidratos/genética , Biologia Computacional/métodos , AMP Cíclico/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Deleção de Genes , Perfilação da Expressão Gênica , Regulação Fúngica da Expressão Gênica/efeitos dos fármacos , Ontologia Genética , Glucose/farmacologia , Proteínas Facilitadoras de Transporte de Glucose/genética , Fenótipo , Ligação Proteica , Transporte Proteico , Transdução de Sinais/efeitos dos fármacos , Transcrição Gênica , Proteínas ras/metabolismoRESUMO
Nicotiana alata defensins 1 and 2 (NaD1 and NaD2) are plant defensins from the ornamental tobacco that have antifungal activity against a variety of fungal pathogens. Some plant defensins interact with fungal cell wall O-glycosylated proteins. Therefore, we investigated if this was the case for NaD1 and NaD2, by assessing the sensitivity of the three Aspergillus nidulans (An) O-mannosyltransferase (pmt) knockout (KO) mutants (An∆pmtA, An∆pmtB, and An∆pmtC). An∆pmtA was resistant to both defensins, while An∆pmtC was resistant to NaD2 only, suggesting NaD1 and NaD2 are unlikely to have a general interaction with O-linked side chains. Further evidence of this difference in the antifungal mechanism was provided by the dissimilarity of the NaD1 and NaD2 sensitivities of the Fusarium oxysporum f. sp. lycopersici (Fol) signalling knockout mutants from the cell wall integrity (CWI) and high osmolarity glycerol (HOG) mitogen-activated protein kinase (MAPK) pathways. HOG pathway mutants were sensitive to both NaD1 and NaD2, while CWI pathway mutants only displayed sensitivity to NaD2.
Assuntos
Aspergillus nidulans/efeitos dos fármacos , Defensinas/farmacologia , Fusarium/efeitos dos fármacos , Nicotiana/química , Pressão Osmótica , Aspergillus nidulans/genética , Aspergillus nidulans/metabolismo , Parede Celular/efeitos dos fármacos , Parede Celular/metabolismo , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Fusarium/genética , Fusarium/metabolismo , Sistema de Sinalização das MAP Quinases , Manosiltransferases/genética , Manosiltransferases/metabolismoRESUMO
Pioglitazone (PTZ) is an oral antidiabetic agent whose anti-cancer properties have been described recently. Since PTZ increases the production of reactive oxygen species in mammalian cells, the aim of current study was to evaluate the cytotoxic, mutagenic and recombinogenic effects of PTZ using respectively the in vitro mitotic index assay and the in vitro mammalian cell micronucleus test in human peripheral lymphocytes, and the in vivo homozygotization assay in Aspergillus nidulans, which detects the loss of heterozygosity due to somatic recombination. Although the lowest PTZ concentrations (4-36 µM) did not show any significant rise in the micronucleus production, the higher PTZ concentration (108 µM) produced a statistically higher number of micronuclei than the negative control and significantly altered the cell-proliferation kinetics, demonstrating the mutagenic and antiproliferative effects of PTZ, respectively. The recombinogenic activity of PTZ, demonstrated here for the first time, was observed at the highest tested concentration (400 µM) through the homozygotization index rates significantly different from the negative control. Taken together, our results show that PTZ is genotoxic at a concentration higher than the therapeutic plasma concentration. This PTZ genotoxicity may be a potential benefit to its previously described antitumour activity.
Assuntos
Dano ao DNA , Linfócitos/efeitos dos fármacos , Micronúcleos com Defeito Cromossômico/induzido quimicamente , PPAR gama/agonistas , Tiazolidinedionas/efeitos adversos , Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/genética , Células Cultivadas , DNA/efeitos dos fármacos , Humanos , Hipoglicemiantes/efeitos adversos , Hipoglicemiantes/uso terapêutico , Hipoglicemiantes/toxicidade , Perda de Heterozigosidade , Testes de Mutagenicidade , Estresse Oxidativo/efeitos dos fármacos , Pioglitazona , Tiazolidinedionas/uso terapêutico , Tiazolidinedionas/toxicidadeAssuntos
Aspergilose/microbiologia , Aspergillus nidulans/isolamento & purificação , Micetoma/microbiologia , Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Aspergilose/diagnóstico , Aspergilose/tratamento farmacológico , Aspergillus nidulans/classificação , Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/genética , Biópsia , DNA Fúngico/genética , Substituição de Medicamentos , Fluconazol/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Micetoma/diagnóstico , Micetoma/tratamento farmacológico , Análise de Sequência de DNARESUMO
Small, cysteine-rich, highly stable antifungal proteins secreted by filamentous Ascomycetes have great potential for the development of novel antifungal strategies. However, their practical application is still limited due to their not fully clarified mode of action. The aim of this work was to provide a deep insight into the antifungal mechanism of Neosartorya fischeri antifungal protein (NFAP), a novel representative of this protein group. Within a short exposure time to NFAP, reduced cellular metabolism, apoptosis induction, changes in the actin distribution and chitin deposition at the hyphal tip were observed in NFAP-sensitive Aspergillus nidulans. NFAP did show neither a direct membrane disrupting-effect nor uptake by endocytosis. Investigation of A. nidulans signalling mutants revealed that NFAP activates the cAMP/protein kinase A pathway via G-protein signalling which leads to apoptosis and inhibition of polar growth. In contrast, NFAP does not have any influence on the cell wall integrity pathway, but an unknown cell wall integrity pathway-independent mitogen activated protein kinase A-activated target is assumed to be involved in the cell death induction. Taken together, it was concluded that NFAP shows similarities, but also differences in its mode of antifungal action compared to two most investigated NFAP-related proteins from Aspergillus giganteus and Penicillium chrysogenum.
Assuntos
Antifúngicos/farmacologia , Proteínas Fúngicas/farmacologia , Neosartorya/química , Actinas/metabolismo , Apoptose/efeitos dos fármacos , Aspergillus nidulans/citologia , Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/crescimento & desenvolvimento , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Parede Celular/efeitos dos fármacos , Parede Celular/metabolismo , Quitina/metabolismo , Endocitose/efeitos dos fármacos , Proteínas de Ligação ao GTP/metabolismo , Hifas/citologia , Hifas/efeitos dos fármacos , Viabilidade Microbiana/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacosRESUMO
Este artigo propõe estudar os primeiros 12 anos de existência do Instituto de Radium de Minas Gerais, fundado em 1922. Sua atuação na luta contra o câncer no Brasil, ainda pouco conhecida, começa a ser esboçada pelo estudo de documentação institucional inédita. Através de um banco de dados elaborado com informações constantes em seu livro de registro de pacientes, foram feitos levantamentos estatísticos dos tipos de câncer e das formas de tratamento existentes entre 1923 e 1935. Esse livro faz parte de um conjunto de outros cinco recentemente descobertos no Centro de Memória da Medicina/UFMG. A documentação permite resgatar os primórdios das intervenções de radioterapia no país e acompanhar seu desenvolvimento e a influência exercida por esse hospital modelo.
This article proposes to study the first 12 years of the Minas Gerais Radium Institute, founded in 1922. Its work in the fight against cancer in Brazil, albeit still little known, is coming to light as its institutional documents are studied. A database has been prepared using information from its patient register, based on which statistical analyses have been done to identify the types of cancer and treatments available there between 1923 and 1935. This register is one of five recently unearthed at the Medicine Memory Center of the Universidade Federal de Minas Gerais. Through them, the earliest experiments in radiotherapy in Brazil can be reconstituted, and its development and the influence of this model hospital can be mapped out.
Assuntos
Feminino , Humanos , Masculino , Aspergillus nidulans/enzimologia , Dioxigenases , Ácido Homogentísico/análise , Oxigenases/metabolismo , Espectrofotometria/métodos , Alcaptonúria/metabolismo , Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/metabolismo , Cromatografia Líquida de Alta Pressão , Ácido Homogentísico/metabolismo , Ácido Homogentísico/urina , Oxigenases/genética , Fenilacetatos/metabolismo , Fenilacetatos/farmacologia , Sensibilidade e EspecificidadeRESUMO
4-Nitroquinoline 1-oxide (4-NQO) is a highly carcinogenic chemical that induces mutations in bacteria, fungi, and animals through the formation of bulky purine adducts. 4-NQO has been used as a mutagen for genetic screens and in both the study of DNA damage and DNA repair. In the model eukaryote Aspergillus nidulans, 4-NQO-based genetic screens have been used to study diverse processes, including gene regulation, mitosis, metabolism, organelle transport, and septation. Early work during the 1970s using bacterial and yeast mutation tester strains concluded that 4-NQO was a guanine-specific mutagen. However, these strains were limited in their ability to determine full mutagenic potential, as they could not identify mutations at multiple sites, unlinked suppressor mutations, or G:C to C:G transversions. We have now used a whole genome resequencing approach with mutant strains generated from two independent genetic screens to determine the full mutagenic spectrum of 4-NQO in A. nidulans. Analysis of 3994 mutations from 38 mutant strains reveals that 4-NQO induces substitutions in both guanine and adenine residues, although with a 19-fold preference for guanine. We found no association between mutation load and mutagen dose and observed no sequence bias in the residues flanking the mutated purine base. The mutations were distributed randomly throughout most of the genome. Our data provide new evidence that 4-NQO can potentially target all base pairs. Furthermore, we predict that current practices for 4-NQO-induced mutagenesis are sufficient to reach gene saturation for genetic screens with feasible identification of causative mutations via whole genome resequencing.
Assuntos
4-Nitroquinolina-1-Óxido/toxicidade , Aspergillus nidulans/efeitos dos fármacos , Aspergillus nidulans/genética , Genoma Fúngico/efeitos dos fármacos , Mutagênese/efeitos dos fármacos , 4-Nitroquinolina-1-Óxido/química , Adenina/química , Dano ao DNA/genética , Guanina/química , Sequenciamento de Nucleotídeos em Larga Escala , Fenótipo , Mutação Puntual , Análise de Sequência de DNARESUMO
Conidial germination is fundamentally important to the growth and dissemination of most fungi. It has been previously shown (K. Hayer, M. Stratford, and D. B. Archer, Appl. Environ. Microbiol. 79:6924-6931, 2013, http://dx.doi.org/10.1128/AEM.02061-13), using sugar analogs, that germination is a 2-stage process involving triggering of germination and then nutrient uptake for hyphal outgrowth. In the present study, we tested this 2-stage germination process using a series of nitrogen-containing compounds for the ability to trigger the breaking of dormancy of Aspergillus niger conidia and then to support the formation of hyphae by acting as nitrogen sources. Triggering and germination were also compared between A. niger and Aspergillus nidulans using 2-deoxy-D-glucose (trigger), D-galactose (nontrigger in A. niger but trigger in A. nidulans), and an N source (required in A. niger but not in A. nidulans). Although most of the nitrogen compounds studied served as nitrogen sources for growth, only some nitrogen compounds could trigger germination of A. niger conidia, and all were related to L-amino acids. Using L-amino acid analogs without either the amine or the carboxylic acid group revealed that both the amine and carboxylic acid groups were essential for an L-amino acid to serve as a trigger molecule. Generally, conidia were able to sense and recognize nitrogen compounds that fitted into a specific size range. There was no evidence of uptake of either triggering or nontriggering compounds over the first 90 min of A. niger conidial germination, suggesting that the germination trigger sensors are not located within the spore.
Assuntos
Aminoácidos/farmacologia , Aspergillus nidulans/efeitos dos fármacos , Aspergillus niger/efeitos dos fármacos , Compostos de Nitrogênio/farmacologia , Esporos Fúngicos/efeitos dos fármacos , Aspergillus nidulans/crescimento & desenvolvimento , Aspergillus niger/crescimento & desenvolvimento , Radioisótopos de Carbono/análise , Cisteína/farmacologia , Desoxiglucose/farmacologia , Galactose/farmacologia , Hifas , Serina/farmacologia , Esporos Fúngicos/crescimento & desenvolvimento , Valina/farmacologiaRESUMO
Carboxymethyl chitosan (CMCS) was synthesized by alkylation of chitosan using monochloroacetic acid and characterized by FTIR and (1)H-NMR spectroscopies. Different molecular weights (Mws) of CMCS were prepared by radiation degradation of CMCS in the solution form at different irradiation doses. The structural changes and Mw of degraded CMCS were confirmed by UV-Vis, FTIR and GPC. The antioxidant activity of CMCS was evaluated using scavenging effect on DPPH radicals, reducing power and ferrous ion chelating activity assays. The antioxidant activity of CMCS enhanced with decreasing CMCS Mw. The possible practical use of CMCS as preservative coating for peach fruit by dipping treatment after 10 days of storage at ambient temperature was investigated. The CMCS with lower Mw had a good effect on delaying spoilage and decreasing malondialdehyde (MDA) content of peach fruits suggesting their possible use as antioxidant and preservative coating.
Assuntos
Anti-Infecciosos/química , Antioxidantes/química , Quitosana/análogos & derivados , Conservantes de Alimentos/química , Raios gama , Anti-Infecciosos/farmacologia , Anti-Infecciosos/efeitos da radiação , Antioxidantes/farmacologia , Antioxidantes/efeitos da radiação , Aspergillus nidulans/efeitos dos fármacos , Candida albicans/efeitos dos fármacos , Quitosana/química , Quitosana/farmacologia , Quitosana/efeitos da radiação , Escherichia coli/efeitos dos fármacos , Conservação de Alimentos , Conservantes de Alimentos/farmacologia , Conservantes de Alimentos/efeitos da radiação , Frutas/efeitos dos fármacos , Prunus/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacosRESUMO
The increasing tolerance to currently-used fungicides is a major problem both in clinical and agricultural areas leading to an urgent need for the development of novel antifungal strategies. This study investigated the in vitro antimicrobial photo treatment (APT) of conidia of the plant-pathogenic fungus Colletotrichum acutatum and the ascomycete Aspergillus nidulans with the furocoumarins 8-methoxypsoralen (8-MOP) and isopimpinellin, and a mixture of two coumarins (7-methoxy coumarin and citropten). Subcellular localization of the photosensitizer 8-MOP was also determined in C. acutatum conidia. Additionally, the effects of APT on the leaves of the plant host Citrus sinensis were determined. APT with 8-MOP (50µM) led to a reduction of approximately 4 logs in the survival of the conidia of both species, and the mixture of the two coumarins (12.5mgL(-1)) resulted in a reduction of approximately 4 logs for A. nidulans and 3 logs for C. acutatum. Isopimpinellin (50µM) displayed a reduction of 4 logs for A. nidulans but less than 2 logs for C. acutatum. Washing the conidia to remove unbound photosensitizers before light exposure reduced the photodynamic inactivation of C. acutatum both with 8-MOP and the mixture of the two coumarins. The reduction was smaller for A. nidulans. 8-MOP spread throughout the cytoplasm and accumulated in structures such as lipid bodies of C. acutatum conidia. No damage to orange tree leaves was observed after APT with any of the photosensitizers.
Assuntos
Antifúngicos/farmacologia , Aspergillus nidulans/efeitos dos fármacos , Colletotrichum/efeitos dos fármacos , Cumarínicos/farmacologia , Furocumarinas/farmacologia , Metoxaleno/farmacologia , Citrus/química , Citrus/microbiologia , Colletotrichum/patogenicidade , Cumarínicos/química , Cumarínicos/isolamento & purificação , Furocumarinas/isolamento & purificação , Metoxaleno/isolamento & purificação , Estrutura Molecular , Fármacos Fotossensibilizantes/farmacologia , Folhas de Planta/efeitos dos fármacos , Folhas de Planta/microbiologia , Esporos Fúngicos/efeitos dos fármacos , Luz SolarRESUMO
Mitotic recombination is a process involved in carcinogenesis which can lead to genetic loss through the loss of heterozygosity. The recombinogenic potentials of two anticancer drugs topoisomerase I inhibitors, camptothecin (CPT) and irinotecan (CPT-11), were evaluated in the present study. The homozygotization assay, which assess the induction of mitotic recombination and gene homozygosis, as well as the heterozygous A757//UT448 diploid strain of Aspergillus nidulans were employed. The three non-cytotoxic concentrations of CPT (3.5 ng mL-1, 10.5 ng mL-1 and 17.4 ng mL-1) were found to induce both mitotic recombination and gene homozygosis. CPT treatment produced three diploids homozygous, for nutritional and conidia color genes, and Homozygotization Indices (HI) significantly different from negative control. On the other hand, only the highest CPT-11 concentration tested (18 µg mL-1), corresponding to the maximal single chemotherapeutic dose, produced HI values higher than 2.0 and significantly different from negative control HI values. The recombinogenic effects of both topoisomerase I blockers were associated with the recombinational repair of DNA strand breaks induced by CPT and CPT-11. The anticancer drugs CPT and CPT-11 may be characterized as secondary malignancies promoters in cancer patients after chemotherapy treatment.
Assuntos
Aspergillus nidulans/efeitos dos fármacos , Camptotecina/análogos & derivados , Camptotecina/toxicidade , Recombinação Genética/efeitos dos fármacos , Inibidores da Topoisomerase I/toxicidade , Aspergillus nidulans/genética , Diploide , Homozigoto , Irinotecano , Mitose/efeitos dos fármacos , Mitose/genética , Testes de MutagenicidadeRESUMO
Metformin is a hypoglycemiant drug prescribed for the treatment and control of the type 2 diabetes mellitus. Recently, the potential efficacy of this antidiabetic drug as an anticancer agent has been demonstrated in various mammalian cancer cells. This report evaluates the mutagenic as well as the recombinogenic potentials of the metformin drug in therapeutically relevant plasma concentrations (12.5 µM, 25.0 µM or 50.0 µM). Since the loss of heterozygosity is a process associated with carcinogenesis, the recombinogenic potential of such a drug was evaluated by the homozygotization assay using a heterozygous diploid strain of Aspergillus nidulans. The homozigotization indices (HI) for the genetic markers from the metformin-treated diploids were not statistically different from the negative control (non-treated diploids). For the first time, this indicated a lack of recombinogenic activity of the antidiabetic drug. The mutagenic potential of the metformin drug was evaluated by the chromosome aberrations and the micronuclei tests in human lymphocytes cultures. The metformin drug did not show any significant increase either in the numerical or in the structural chromosome aberrations and did not affect significantly the mitotic index when compared to the negative control. In the in vitro micronucleus test, the drug did not increase the number of micronuclei or nuclear buds when compared with the negative control. The data in this study suggest that the metformin drug is not a secondary cancer inducer, since it has neither showed recombinogenic nor mutagenic activities when used in pharmacological concentrations.
Assuntos
Metformina/toxicidade , Mutagênicos/toxicidade , Adulto , Aspergillus nidulans/citologia , Aspergillus nidulans/efeitos dos fármacos , Cromátides/metabolismo , Aberrações Cromossômicas/efeitos dos fármacos , Segregação de Cromossomos/efeitos dos fármacos , Cromossomos de Mamíferos/metabolismo , Diploide , Feminino , Haploidia , Heterozigoto , Homozigoto , Humanos , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Masculino , Testes para Micronúcleos , Índice Mitótico , Adulto JovemRESUMO
Invasive aspergillosis is a major threat to patients with chronic granulomatous disease (CGD). Fungal pathogenesis is the result of a diminished antifungal capacity and dysregulated inflammation. A deficient NADPH-oxidase complex results in defective phagolysosomal alkalization. To investigate the contribution of defective pH regulation in phagocytes among patients with CGD during fungal pathogenesis, we evaluated the effect of the acidotropic, antimalarial drug chloroquine (CQ) on the antifungal capacity of polymorphonuclear cells (PMNs) and on the inflammatory response of peripheral blood mononuclear cells (PBMCs). Chloroquine exerted a direct pH-dependent antifungal effect on Aspergillus fumigatus and Aspergillus nidulans; it increased the antifungal activity of PMNs from patients with CGD at a significantly lower concentration, compared with the concentration for PMNs from healthy individuals; and decreased the hyperinflammatory state of PBMCs from patients with CGD, as observed by decreased tumor necrosis factor α and interleukin 1ß release. Chloroquine targets both limbs of fungal pathogenesis and might be of great value in the clearance of invasive aspergillosis in patients with CGD.
Assuntos
Aspergilose/imunologia , Aspergillus fumigatus/imunologia , Aspergillus nidulans/imunologia , Cloroquina/farmacologia , Doença Granulomatosa Crônica/microbiologia , Fagócitos/imunologia , Antifúngicos/farmacologia , Antimaláricos/farmacologia , Aspergilose/complicações , Aspergilose/microbiologia , Aspergillus fumigatus/efeitos dos fármacos , Aspergillus nidulans/efeitos dos fármacos , Citocinas/metabolismo , Relação Dose-Resposta a Droga , Doença Granulomatosa Crônica/complicações , Doença Granulomatosa Crônica/imunologia , Humanos , Concentração de Íons de Hidrogênio , Glicoproteínas de Membrana/deficiência , Glicoproteínas de Membrana/genética , NADPH Oxidase 2 , NADPH Oxidases/deficiência , NADPH Oxidases/genética , Fagócitos/efeitos dos fármacos , Fagócitos/microbiologia , Fagossomos/efeitos dos fármacos , Fagossomos/imunologia , Fagossomos/microbiologiaRESUMO
Imidocarb dipropionate (IMD) is a chemotherapeutic agent prescribed for the treatment and control of babesiosis; it is known to be a nucleic acid synthesis inhibitor. Although it is an effective babesicide, there are reports of persistent IMD residues retained at high levels in edible tissues of cattle, swine and sheep, raising concerns about potential effects on humans. Since the carcinogenic potential of a chemical compound can be assessed through its effect on the homologous recombination, we investigated whether IMD is recombinogenic in Aspergillus nidulans diploid cells and whether it is capable of inducing homozygosis in genes that were previously heterozygous. This analysis was done with a homozygotization assay applied to a heterozygous diploid strain of A. nidulans. IMD used at non-toxic concentrations (2.5 to 10.0 µM) was recombinogenic, demonstrated by homozygotization indices higher than 2.0 for diploid markers. A diploid homozygous for genetic markers from chromosomes I and II was also produced. Since DNA replication blockers that induce DNA strand breaks have been classified as potent inducers of homologous recombination, the recombinogenic potential of IMD may be due to induction of recombinational repair.